SciELO - Scientific Electronic Library Online

vol.129 número8Formulación de una mezcla vitamínica intravenosa para nutrición parenteral total pediátricaSíndrome de Münchausen por poder: una presentación inusual índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Revista médica de Chile

versión impresa ISSN 0034-9887


GALLARDO E, Jorge et al. Gemcitabine in the treatment of cholangiocarcinoma.. Rev. méd. Chile [online]. 2001, vol.129, n.8, pp. 911-916. ISSN 0034-9887.

Cholangiocarcinoma is a biliary tree cancer of unknown etiology, whose symptoms are unspecific and is usually detected in advanced stages. Surgery continues to be the only curative therapy. Median survival in patients with inoperable tumors ranges between 5 and 8 months. There are few studies on the effects of chemotherapy, with a very small response. We report four patients with advanced cholangiocarcinoma, treated with gemcitabine 1000 mg/m2, weekly for 3 weeks every 28 days. There was a stabilization of tumor size and symptoms were alleviated. Toxicity was low and there was a probable prolongation of survival (Rev Méd Chile 2001; 911-6).

Palabras clave : Cholangiocarcinoma; Cholangiography; Gemcitabine.

        · texto en Español